Making human immune systems more interpretable through systems immunology
Trends in Immunology · 2023-08 · 44 (8) · 577-584
DOI: 10.1016/j.it.2023.06.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2023-08. Verfasst von Rikard Forlin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Clinical Pediatrics, Department of Women's and Children's Health, Karolinska Institutet, 17165, Solna, Sweden. Hauptthemen laut MEDLINE: Immunity, Immune System. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Svenska Sällskapet för Medicinsk Forskning, Knut och Alice Wallenbergs Stiftelse, Swedish Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit for Clinical Pediatrics, Department of Women's and Children's Health, Karolinska Institutet, 17165, Solna, Sweden.
- Unit for Clinical Pediatrics, Department of Women's and Children's Health, Karolinska Institutet, 17165, Solna, Sweden; Department of Immunology and Inflammation, Imperial College London, London W12 0NN, UK; Medical Res…
Förderung
- Svenska Sällskapet för Medicinsk Forskning
- Knut och Alice Wallenbergs Stiftelse
- Swedish Research Council
Zitieren
APA
Forlin, R., James, A., & Brodin, P. (2023). Making human immune systems more interpretable through systems immunology. Trends in Immunology, 44(8), 577-584. https://doi.org/10.1016/j.it.2023.06.005
Vancouver
Forlin R, James A, Brodin P. Making human immune systems more interpretable through systems immunology. Trends in Immunology. 2023;44(8):577-584. doi:10.1016/j.it.2023.06.005
BibTeX
@article{Forlin2023,
author = {Forlin, Rikard and James, Anna and Brodin, Petter},
title = {Making human immune systems more interpretable through systems immunology},
journal = {Trends in Immunology},
year = {2023},
volume = {44},
number = {8},
pages = {577--584},
doi = {10.1016/j.it.2023.06.005}
}
EUVIMED